Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Nabhan, Samir Kanaan  [Clear All Filters]
2024
Medeiros GRosendo de, Funke VAraújo Mo, Lima ACardoso Ma, Mion ALúcia Vie, Menezes I, Setubal DCarinhanha, Sola CBonamin Do, Tagliari G, Marchesini R, Nabhan SKanaan, et al. THE ROLE OF MOLECULAR OR CYTOGENETIC RESPONSE AS A FAVORABLE PROGNOSTIC FACTOR BEFORE HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CHRONIC MYELOID LEUKEMIA. Transplant Cell Ther. 2024.
2023
Santos ESbrana, Lima ACardoso Ma, Breda GLuís, Tomaz APaula de O, Nabhan SKanaan, Funke VAraújo Mo, Loth G, Nogueira Kda Silva. Colonization by multidrug-resistant bacteria in hematological patients undergoing hematopoietic stem cell transplantation and clinical outcomes: A single-center retrospective cohort study. Transpl Infect Dis. 2023:e14119.
2022
Bonfim C, Nichele S, Loth G, Funke VAraújo Mo, Nabhan SKanaan, Pillonetto DVandresen, Lima ACardoso Ma, Pasquini R. Transplantation for Fanconi anaemia: lessons learned from Brazil. Lancet Haematol. 2022;9(3):e228-e236.
2020
Arcuri LJavier, Nabhan SKanaan, Loth G, Atta EHallack, Oliveira M, Nichele S, Araujo Rde Castro, Bonfim C. A case series of post-transplant cyclophosphamide in unrelated donor hematopoietic transplantation for aplastic anemia. Biol Blood Marrow Transplant. 2020.
Arcuri LJavier, Nabhan SKanaan, Cunha R, Nichele S, Ribeiro AAlice Feit, Fernandes JFolloni, Daudt LEsteves, Rodrigues ALuiza Melo, Arrais-Rodrigues C, Seber A, et al. Impact of CD34 cell dose and conditioning regimen on outcomes after Haploidentical donor hematopoietic stem cell transplantation with post-transplant cyclophosphamide for relapsed/refractory severe aplastic anemia: Haploidentical HCT with PTCy for SAA. Biol Blood Marrow Transplant. 2020.